World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
89
Citations
32676
World Ranking
12585
National Ranking
135

Leif Thuesen publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Leif Thuesen sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 424 publications — 44th percentile

44% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Leif Thuesen D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Leif Thuesen sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 89 D-Index — 38th percentile

38% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Leif Thuesen is affiliated with Aalborg University in Denmark and specializes in the field of Medicine, with a focus on surgery, cardiology and cardiovascular medicine, and radiology, nuclear medicine, and imaging. Their research encompasses subfields including biomedical engineering and pulmonary and respiratory medicine.

The scientist's main topics of work include coronary interventions and diagnostics, cardiac imaging and diagnostics, acute myocardial infarction research, antiplatelet therapy and cardiovascular diseases, advanced X-ray and CT imaging, cardiac, anesthesia and surgical outcomes, and treatments for aortic aneurysm repair.

Frequent publication venues for Thuesen comprise Circulation, EuroIntervention, Open Heart, Cardiovascular Revascularization Medicine, and Cardiology.

  • Intravascular ultrasound to guide left main stem intervention: a NOBLE trial substudy, 2020, EuroIntervention
  • Randomized Comparison of the Polymer-Free Biolimus-Coated BioFreedom Stent With the Ultrathin Strut Biodegradable Polymer Sirolimus-Eluting Orsiro Stent in an All-Comers Population Treated With Percutaneous Coronary Intervention, 2020, Circulation
  • Randomised comparison of provisional side branch stenting versus a two-stent strategy for treatment of true coronary bifurcation lesions involving a large side branch: the Nordic-Baltic Bifurcation Study IV, 2020, Open Heart
  • Randomized Clinical Comparison of the Dual-Therapy CD34 Antibody-Covered Sirolimus-Eluting Combo Stent With the Sirolimus-Eluting Orsiro Stent in Patients Treated With Percutaneous Coronary Intervention: The SORT OUT X Trial, 2021, Circulation
  • Age-Stratified Outcome in Treatment of Left Main Coronary Artery Stenosis: A NOBLE Trial Substudy, 2021, Cardiology

  • Evald Høj Christiansen (8 coauthored works)
  • Andrejs Ērglis (5 coauthored works)
  • Lisette Okkels Jensen (5 coauthored works)
  • Martin Kirk Christensen (5 coauthored works)
  • Niels Ramsing Holm (4 coauthored works)

Best Publications

  • A Comparison of Coronary Angioplasty with Fibrinolytic Therapy in Acute Myocardial Infarction

    Henning R. Andersen;Torsten T. Nielsen;Klaus Rasmussen;Leif Thuesen

  • Long-term follow-up of patients from a randomised trial of atrial versus ventricular pacing for sick-sinus syndrome

    Henning Rud Andersen;Jens Cosedis Nielsen;Poul Erik Bloch Thomsen;Leif Thuesen

  • BENEFICIAL EFFECTS OF GROWTH HORMONE TREATMENT IN GH-DEFICIENT ADULTS

    J O Jørgensen;S A Pedersen;L Thuesen;J Jørgensen

  • A bioabsorbable everolimus-eluting coronary stent system (ABSORB): 2-year outcomes and results from multiple imaging methods

    Patrick W Serruys;John A Ormiston;Yoshinobu Onuma;Evelyn Regar

  • Randomized study on simple versus complex stenting of coronary artery bifurcation lesions: the Nordic bifurcation study

    Terje K. Steigen;Michael Maeng;Rune Wiseth;Andrejs Erglis

  • Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial

    Hans Erik Bøtker;Rajesh Kharbanda;Michael R Schmidt;Morten Bøttcher

  • A bioabsorbable everolimus-eluting coronary stent system for patients with single de-novo coronary artery lesions (ABSORB): a prospective open-label trial

    John A Ormiston;Patrick W Serruys;Evelyn Regar;Dariusz Dudek

  • Percutaneous coronary angioplasty versus coronary artery bypass grafting in treatment of unprotected left main stenosis (NOBLE): a prospective, randomised, open-label, non-inferiority trial.

    Timo Mäkikallio;Niels R Holm;Mitchell Lindsay;Mark S Spence

  • System Delay and Mortality Among Patients With STEMI Treated With Primary Percutaneous Coronary Intervention

    Christian Juhl Terkelsen;Jacob Thorsted Sørensen;Michael Maeng;Lisette Okkels Jensen

  • Evaluation of the Second Generation of a Bioresorbable Everolimus-Eluting Vascular Scaffold for the Treatment of De Novo Coronary Artery Stenosis: 12-Month Clinical and Imaging Outcomes

    Patrick W. Serruys;Yoshinobu Onuma;Dariusz Dudek;Pieter C. Smits

  • Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: the Euroinject One trial.

    Jens Kastrup;Erik Jørgensen;Andreas Rück;Kristina Tägil

  • Prospective randomised trial of atrial versus ventricular pacing in sick-sinus syndrome

    H.R Andersen;L Thuesen;J.P Bagger;T Vesterlund

  • Exenatide reduces reperfusion injury in patients with ST-segment elevation myocardial infarction

    Jacob Lønborg;Niels Vejlstrup;Henning Kelbæk;Hans Erik Bøtker

  • Clinical Efficacy of Polymer-Based Paclitaxel-Eluting Stents in the Treatment of Complex, Long Coronary Artery Lesions From a Multicenter, Randomized Trial Support for the Use of Drug-Eluting Stents in Contemporary Clinical Practice

    Keith D. Dawkins;Eberhard Grube;Giulio Guagliumi;Adrian P. Banning

  • A randomised comparison of an everolimus-eluting coronary stent with a paclitaxel-eluting coronary stent:the SPIRIT II trial.

    Patrick W Serruys;Peter Ruygrok;Jörg Neuzner;Jan J Piek

  • A randomized comparison of a durable polymer Everolimus-eluting stent with a bare metal coronary stent: The SPIRIT first trial

    Patrick W. Serruys;Andrew T. L. Ong;Jan J. Piek;Franz-Josef Neumann

  • In-hospital outcomes of percutaneous coronary intervention in patients with chronic total occlusion: insights from the ERCTO (European Registry of Chronic Total Occlusion) registry.

    Alfredo R Galassi;Salvatore D Tomasello;Nicolaus Reifart;Gerald S Werner

  • Percutaneous coronary angioplasty versus coronary artery bypass grafting in the treatment of unprotected left main stenosis: updated 5-year outcomes from the randomised, non-inferiority NOBLE trial

    Niels R Holm;Timo Mäkikallio;M Mitchell Lindsay;Mark S Spence

  • Evaluation of the Second Generation of a Bioresorbable Everolimus Drug-Eluting Vascular Scaffold for Treatment of De Novo Coronary Artery StenosisClinical Perspective

    Patrick W. Serruys;Yoshinobu Onuma;John A. Ormiston;Bernard de Bruyne

  • Electromechanical mapping for detection of myocardial viability in patients with ischemic cardiomyopathy.

    Hans Erik Bøtker;Jens Flensted Lassen;Flemming Hermansen;Henrik Wiggers

Frequent Co-Authors

Jens Flensted Lassen
Jens Flensted Lassen University of Southern Denmark
Hans Erik Bøtker
Hans Erik Bøtker Aarhus University Hospital
Patrick W. Serruys
Patrick W. Serruys University of Galway
Henrik Toft Sørensen
Henrik Toft Sørensen Aarhus University
Hector M. Garcia-Garcia
Hector M. Garcia-Garcia MedStar Washington Hospital Center
Dariusz Dudek
Dariusz Dudek Jagiellonian University
Yoshinobu Onuma
Yoshinobu Onuma University of Galway
Stephan Windecker
Stephan Windecker University of Bern
Steen Dalby Kristensen
Steen Dalby Kristensen Aarhus University Hospital
Bernard De Bruyne
Bernard De Bruyne Cardiovascular Center Aalst

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in Medicine doesn’t just mean becoming a physician. Many prospective students consider alternative or complementary pathways—like healthcare administration, nursing practice, or pharmacy—each offering rewarding professional opportunities.

If you’re interested in leadership and want to manage healthcare organizations, a Master of Healthcare Administration (MHA) might be ideal. There are now several options for the cheapest mha programs online for budget-conscious students, as well as a curated list of the cheapest mha programs on-campus or in hybrid format.

Advanced practice nurses may choose a Doctor of Nursing Practice (DNP) for clinical leadership roles. Many institutions now offer most affordable dnp programs that fit around busy work schedules. Meanwhile, the expanding field of pharmacy now includes options for a 3-year online pharmd for aspiring pharmacists looking for flexibility and accelerated graduation.

These online and hybrid programs provide flexible options, reduced costs, and new routes into healthcare careers—opening doors to impact, innovation, and leadership in the U.S. medical system.

Best Scientists Citing Leif Thuesen

Trending Scientists

Recently Published Articles